Study Finds 60% of DSM-5-TR Panel Members Had Undisclosed Financial Ties to Pharmaceutical Industry
By
renameme
Pure flour-power. Hearty enough to carry you through lunch.
Summary
A cross-sectional analysis of 92 US-based physicians who served on DSM-5-TR panels found that 60% received industry payments totaling $14.2 million during 2016-2019. The study reveals widespread undisclosed financial conflicts of interest among panel members responsible for developing the Diagnostic and Statistical Manual of Mental Disorders, with one-third of task force members also receiving payments. The researchers recommend prohibiting conflicts of interest for decision-makers on such influential diagnostic guideline panels.
Key quotes
· 4 pulledOf these 92 individuals, 55 (60%) received payments from industry. Collectively, these panel members received a total of $14.2m
One third (33.3%) of the task force members had payments reported in Open Payments
Conflicts of interest among panel members of DSM-5-TR were prevalent
A rebuttable presumption should exist for the Diagnostic and Statistical Manual of Mental Disorders to prohibit conflicts of interest among its panel and task force members
You might also wanna read
The costly failure of amyloid-beta drugs: A cautionary tale in pharmaceutical development
The article discusses drug classes that are perceived as failures after massive investment and clinical trials, using amyloid-beta drugs for
AI Health Advice Leads to Psychosis: A Case of Bromide Toxicity
A 60-year-old man developed psychosis due to bromide toxicity after following health advice from ChatGPT, highlighting the risks of relying
Genomic test trial suggests hormone therapy alone may be sufficient for low-risk breast cancer patients
A groundbreaking genomic test trial suggests that breast cancer patients with low test scores could be treated with hormone therapy alone, a

Study finds bird masturbation is natural behavior, not caused by captivity stress
A study on masturbation among birds, particularly parrots, finds that the behavior is natural and more common in the wild than in captivity.
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
Lab-grown sperm from stem cells could help infertile men, but may require gene editing
A US start-up called Paterna Biosciences claims it can take stem cells from men's testes and grow them into sperm cells in the lab, potentia
